The first six months of 2026 have reinforced one thing: laboratories are no longer being measured solely by the quality of their testing. Financial performance, compliance readiness, operational efficiency, and technology adoption have become equally important to long-term success.
Across the industry, laboratory leaders are adapting to new reimbursement realities, digital compliance requirements, increasing payer scrutiny, and growing staffing challenges. At the same time, many laboratories are finding new opportunities to improve cash flow through automation, analytics, and smarter revenue cycle management.
If the first half of the year has taught us anything, it's this: the laboratories investing in modern billing workflows and operational visibility today will be better prepared for tomorrow's regulatory and financial challenges.
Several significant developments have shaped laboratory operations since January.
PAMA Remains One of the Biggest Financial Stories
One of the most closely watched issues continues to be reimbursement under the Protecting Access to Medicare Act (PAMA). CMS recently confirmed that private payer reporting remains active through July 31, 2026, while payment reductions remain delayed until 2027 under current legislation. Laboratories should continue preparing for future reimbursement changes while ensuring accurate reporting today. Although reimbursement reductions have been postponed, laboratory organizations continue advocating for long-term legislative reform through the RESULTS Act.
Compliance Expectations Continue to Increase
Federal agencies continue moving toward digital oversight and faster validation of laboratory credentials and regulatory information. Rather than periodic reviews, laboratories should expect more real-time verification of information submitted to payers and government programs. For revenue cycle leaders, this means compliance and billing can no longer operate independently.
Staffing Challenges Continue
Finding experienced laboratory billing professionals remains difficult. Many organizations are responding by investing in automation rather than expanding headcount. That trend has accelerated significantly during the first half of the year and is expected to continue throughout 2026.
What ADS Is Seeing Across Laboratory Clients
Working with laboratories nationwide provides unique insight into what separates high-performing organizations from those struggling with reimbursement. The laboratories seeing the strongest financial results typically share several characteristics: high first-pass claim acceptance rates, strong eligibility verification before testing, automated payer-specific claim edits, proactive denial management, real-time revenue dashboards, and tight integration between laboratory operations and billing. Most importantly, they treat revenue cycle management as an ongoing performance strategy, not simply a billing function.
Five Priorities for the Second Half of 2026
As laboratories prepare for the remainder of the year, these areas deserve continued attention:
For nearly five decades, ADS has helped laboratories improve financial performance through specialized technology and revenue cycle expertise. Whether your laboratory prefers to keep billing in-house or outsource revenue cycle operations, ADS provides solutions designed specifically for clinical laboratories, pathology groups, molecular diagnostics, toxicology, genetics, and specialty testing.
With ADS, laboratories can improve first-pass claim acceptance, reduce denials before claims are submitted, automate eligibility verification, integrate with virtually any LIS, monitor KPIs through real-time dashboards, streamline billing workflows, and strengthen compliance while improving cash flow.
If you're evaluating technology upgrades or looking to improve collections, explore our dedicated laboratory solutions: Laboratory Billing Software & Revenue Cycle Solutions
Complimentary Mid-Year Laboratory Revenue Assessment
The second half of the year is the ideal time to evaluate your laboratory's financial performance before year-end. Our specialists will review revenue cycle performance, denial trends, aging A/R, billing workflow efficiency, automation opportunities, compliance readiness, and cash flow improvement strategies. Whether you currently manage billing internally or use an outside service, you'll receive practical recommendations your team can implement immediately.
Schedule Your Complimentary Mid-Year Laboratory Revenue Assessment
If the first half of 2026 has demonstrated anything, it's that successful laboratories are becoming increasingly proactive. They're embracing digital operations. They're modernizing revenue cycle management. They're investing in automation. And they're using better financial intelligence to guide strategic decisions.
At ADS, we believe the laboratories that focus on operational excellence today will be the ones best positioned for sustained growth tomorrow. If you'd like to discuss how your laboratory can improve billing performance, reduce denials, and strengthen cash flow during the second half of the year, we're ready to help.